AZ’s Vaccine Mess, Rubius Infiltrates Solid Tumors, & Insitro’s $400M Haul

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.